Walgreens Specialty Pharmacy (WBA) said Tuesday it has expanded its limited distribution drug network to now include 265 products.
The company said medications provided under limited distribution drug networks are often complex or high-cost therapies that may require special handling through specialty pharmacies.
Medications added to the specialty pharmacy network include Gilead's (GILD) Yeztugo, Galderma's Nemluvio and Shorla Oncology's Imkeldi, the company said.
Price: 12.02, Change: +0.02, Percent Change: +0.13
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.